{# max-image-preview:large is what makes an article eligible for the big-image card in Google Discover — without it Google may only show a thumbnail. #} {# ── Google Preferred Sources ──────────────────────────────────────────── Readers who mark us as a preferred source get our fresh articles prioritised in Top Stories, Discover and Google News. Only domain- and subdomain-level sites are eligible — blog.alfafinder.com qualifies, a /news/ subdirectory would not. #}

Glenmark Pharmaceuticals — Latest News

Every announcement Glenmark Pharmaceuticals has filed with the exchanges that we have reported, newest first. Each story links the original filing.

NSE: GLENMARK BSE: 532296 Pharmaceuticals & Biotechnology 3 stories

Price

₹2332.9

Market Cap

₹65,840.20 Cr

Revenue TTM

₹17,736.55 Cr

P/E (TTM)

36.62×

Sector 45.65×

Reference data from Trendlyne, as of the most recent story. Not a valuation or a recommendation.

Product Launched · 3

Track Glenmark Pharmaceuticals in real time

ALFA Finder watches NSE & BSE filings 24/7 and alerts you the moment Glenmark Pharmaceuticals files something material.

Start Free — 15-day trial

{# ── Promo popup — fires 5s after first page load per session. NEVER fires for visitors arriving from a search engine: a full-viewport overlay on a news article is an intrusive interstitial, and Google News policy is explicit that promotional material must not exceed the content. Direct, social and referral traffic still sees it. ─────────── #}